Three Former Executives For Magellan Diagnostics Charged With Conspiracy, Wire Fraud And FDA Violations
BOSTON – The former CEO, COO, and Director of Quality Assurance and Regulatory Affairs for Magellan Diagnostics, Inc. (Magellan), a medical device company headquartered in Billerica, Mass., have been charged in connection with concealing a device malfunction that allegedly produced inaccurately low lead test results for tens of thousands of children and other patients.
Action Details
- Date:April 5, 2023
- Agency:U.S. Attorney's Office, District of Massachusetts
-
Enforcement Types:
- Criminal and Civil Actions